July 7, 2014 / 2:25 PM / 3 years ago

BRIEF-Genmab to receive 25 mln USD milestone payment from Janssen

COPENHAGEN, July 7 (Reuters) - Genmab A/S : * Reaches $25 million milestone in Daratumumab collaboration with Janssen * Milestone triggered by progress in the phase III study of Daratumumab in combination with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma * Milestone payment is included in Genmab's 2014 financial guidance published on May 1, 2014. Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below